MG
AZN icon

Marex Group’s AstraZeneca AZN Stock Holding History

Marex Group’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$764K Buy
4,027
+2,103
+109% +$396K ﹤0.01% 572
2026
Q1 		$379K Buy
+1,924
New +$371K ﹤0.01% 700
2024
Q4 		– Sell
-3,000
Closed -$467K – 692
2024
Q3 		$467K Hold
3,000
– – 0.01% 301
2024
Q2 		$468K Buy
+3,000
New +$451K 0.01% 317

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Marex Group's AZN Position: Q2 2026 in Review

Marex Group increased its AstraZeneca (AZN) stake by 109% in Q2 2026, buying an estimated $396K and bringing the position to 4,027 shares worth $764K. The position accounts for ﹤0.01% of the portfolio, ranked #572.

Marex Group first reported a position in AZN in Q2 2024 and has held it in 4 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Marex Group held 4,027 shares of AstraZeneca worth $764K as of Q2 2026.
  • Marex Group bought 2,103 AstraZeneca shares in Q2 2026, an estimated $396K.
  • AstraZeneca made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #572 holding.
  • Marex Group first reported a position in AstraZeneca in Q2 2024 and has held it in 4 quarters since.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.